- $4.46bn
- $4.48bn
- $910.49m
- 83
- 16
- 74
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 328 | 435 | 610 | 779 | 910 |
Cost of Revenue | |||||
Gross Profit | 193 | 255 | 338 | 411 | 478 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 325 | 454 | 666 | 866 | 1,009 |
Operating Profit | 3.27 | -19.3 | -56.3 | -87.6 | -98.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.45 | -44.6 | -64.3 | -90.3 | -79.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.55 | -42.1 | -53 | -94.7 | -81.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.55 | -42.1 | -53 | -94.7 | -81.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.55 | -42.1 | -53 | -94.7 | -81.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.063 | -0.504 | -0.654 | -1.22 | -1.05 |